Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.44 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.44 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.44 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25063817 | 1.00 | LPAR3 (0.52) | LPAR3LPAR2CYP1A2ALDH1A1CYP3A4 | |
| SCHEMBL25263033 | 1.00 | LPAR3 (0.52) | LPAR3LPAR2CYP1A2ALDH1A1CYP3A4 | |
| SCHEMBL11372070 | 0.96 | CYP1A2 (0.52) | LPAR3LPAR2CYP1A2ALDH1A1CYP3A4 | |
| SCHEMBL27789899 | 0.92 | CYP1A2 (0.55) | LPAR3LPAR2CYP1A2ALDH1A1CYP3A4 | |
| Diethylamine SCHEMBL27831406 | 0.84 | CYP1A2 (0.47) | LPAR3LPAR2CYP1A2GAA | |
| SCHEMBL12227383 | 0.84 | DGKA (0.56) | LPAR3LPAR2TSHRDGKAENPP2 | |
| SCHEMBL1556696 | 0.84 | SMN1; SMN2 (0.50) | LPAR3LPAR2CYP1A2ALDH1A1ALOX15 | |
| SCHEMBL33870 | 0.83 | CYP1A2 (0.70) | CYP1A2ALDH1A1CYP3A4ALOX15TSHR | |
| SCHEMBL495925 | 0.83 | CYP1A2 (0.70) | CYP1A2ALDH1A1CYP3A4ALOX15TSHR | |
| SCHEMBL440349 | 0.83 | CYP1A2 (0.70) | CYP1A2ALDH1A1CYP3A4ALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12163188-B2 | Polymerase compositions and methods | Life Technologies Corporation (US) | 2024-12-10 | — | — | US | disclosed |
| US-20230055565-A1 | POLYMERASE COMPOSITIONS & METHODS | Life Technologies Corporation (US) | 2023-02-23 | — | — | US | disclosed |
| US-11453909-B2 | Polymerase compositions and methods | Life Technologies Corporation (US) | 2022-09-27 | — | — | US | disclosed |
| US-11015220-B2 | Conjugates of biomolecules to nanoparticles | Life Technologies Corporation (US) | 2021-05-25 | — | — | US | disclosed |
| US-11015220-B2 | Conjugates of biomolecules to nanoparticles | Life Technologies Corporation (US) | 2021-05-25 | — | — | US | disclosed |
| US-11008612-B2 | Methods and apparatus for single molecule sequencing using energy transfer detection | Life Technologies Corporation (US) | 2021-05-18 | — | — | US | disclosed |
| US-11008612-B2 | Methods and apparatus for single molecule sequencing using energy transfer detection | Life Technologies Corporation (US) | 2021-05-18 | — | — | US | disclosed |
| US-10093974-B2 | Methods and apparatus for single molecule sequencing using energy transfer detection | Life Technologies Corporation (US) | 2018-10-09 | — | — | US | disclosed |
| US-10093972-B2 | Conjugates of biomolecules to nanoparticles | Life Technologies Corporation (US) | 2018-10-09 | — | — | US | disclosed |
| US-10093973-B2 | Polymerase compositions and methods | Life Technologies Corporation (US) | 2018-10-09 | — | — | US | disclosed |
| US-20110014612-A1 | POLYMERASE COMPOSITIONS & METHODS | Life Technologies Corporation (US) | 2011-01-20 | — | — | US | disclosed |
| US-20110014612-A1 | POLYMERASE COMPOSITIONS & METHODS | Life Technologies Corporation (US) | 2011-01-20 | — | — | US | disclosed |
| WO-2010111691-A9 | CONJUGATES OF BIOMOLECULES TO NANOPARTICLES | LIFE TECHNOLOGIES CORP (US) | 2011-01-06 | — | — | WO | disclosed |
| US-20110003343-A1 | CONJUGATES OF BIOMOLECULES TO NANOPARTICLES | Life Technologies Corporation (US) | 2011-01-06 | — | — | US | disclosed |
| US-20110003343-A1 | CONJUGATES OF BIOMOLECULES TO NANOPARTICLES | Life Technologies Corporation (US) | 2011-01-06 | — | — | US | disclosed |
| US-20100255487-A1 | METHODS AND APPARATUS FOR SINGLE MOLECULE SEQUENCING USING ENERGY TRANSFER DETECTION | Life Technologies Corporation (US) | 2010-10-07 | — | — | US | disclosed |
| WO-2010111691-A2 | CONJUGATES OF BIOMOLECULES TO NANOPARTICLES | LIFE TECHNOLOGIES CORP (US) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010111690-A2 | POLYMERASE COMPOSITIONS AND METHODS | Life Technologies Corporation (US) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010111674-A2 | METHODS AND APPARATUS FOR SINGLE MOLECULE SEQUENCING USING ENERGY TRANSFER DETECTION | Life Technologies Corporation (US) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010039897-A2 | NANOCRYSTALS WITH FUNCTIONAL LIGANDS | Life Technologies Corporation (US) | 2010-04-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11015220-B2 | Conjugates of biomolecules to nanoparticles | POLN, RNGTT, POLI | LPAR3 944/4885LPAR2 1801/4885CYP1A2 3849/4885 |
| US-20110014612-A1 | POLYMERASE COMPOSITIONS & METHODS | POLN, POLI, POLRMT | LPAR3 2299/4885LPAR2 2968/4885CYP1A2 3403/4885 |
| US-10093973-B2 | Polymerase compositions and methods | POLN, POLI, POLRMT | LPAR3 2198/4885LPAR2 3001/4885CYP1A2 3681/4885 |
| US-11453909-B2 | Polymerase compositions and methods | POLN, POLI, POLRMT | LPAR3 2198/4885LPAR2 3001/4885CYP1A2 3681/4885 |
| US-10093974-B2 | Methods and apparatus for single molecule sequencing using energy transfer detection | POLRMT, DNTT, POLM | LPAR3 3839/4885LPAR2 4029/4885CYP1A2 4311/4885 |
| US-11008612-B2 | Methods and apparatus for single molecule sequencing using energy transfer detection | POLRMT, DNTT, POLM | LPAR3 3839/4885LPAR2 4029/4885CYP1A2 4311/4885 |
| US-12163188-B2 | Polymerase compositions and methods | POLN, POLI, POLRMT | LPAR3 2198/4885LPAR2 3001/4885CYP1A2 3681/4885 |
| US-20230055565-A1 | POLYMERASE COMPOSITIONS & METHODS | POLN, POLI, POLRMT | LPAR3 2299/4885LPAR2 2968/4885CYP1A2 3403/4885 |
| US-10093972-B2 | Conjugates of biomolecules to nanoparticles | POLN, RNGTT, POLI | LPAR3 944/4885LPAR2 1801/4885CYP1A2 3849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.